482 COVID-19 in patients with lung cancer receiving immunotherapy. A report from an spanish academic center
Main Authors: | Laura Gutierrez, David Viñal, Julia Villamayor, Oliver Higuera, Dario Sanchez Cabrero, Javier De Castro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Mycetoma: experience of 482 cases in a single center in Mexico.
by: Alexandro Bonifaz, et al.
Published: (2014-08-01) -
482 Deciphering the heterogeneity of B-cell checkpoint inhibitors within tertiary lymphoid structures: Implications for lung cancer immunotherapy
by: Corinne Ramos, et al.
Published: (2023-11-01) -
KIE 482 - SERAMIK OKT-NOV 1991.
by: PPSK, Pusat Pengajian Sains Kimia
Published: (1991) -
KIE 482 - SERAMIK OKT-NOV. 1989
by: PPSK, Pusat Pengajian Sains Kimia
Published: (1989) -
KIE 482 - SERAMIK OKT-NOV 1995
by: PPSK, Pusat Pengajian Sains Kimia
Published: (1995)